Tag: SARS-CoV-2
Salud
Maxwell Biosciences Announces In Vivo and In Vitro Data on CLAROMER™ Platform’s Ability to Treat and Prevent SARS-CoV-2 and Other Respiratory Viruses at OPTIONS XI...
Maxwell Biosciences (“Maxwell"), a preclinical drug platform company focused on the development of synthetic compounds that mimic biomolecules...
Internacional
Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced...
Want to stay up to date with the latest news?
We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!